Gene-editing technique CRISPR identifies dangerous breast cancer mutations
5 (94) · $ 14.00 · In stock
Mutations in BRCA genes are linked to the early onset of breast and ovarian cancers. But the effect of most mutations is unclear. Now new research can distinguish harmless from dangerous mutations.
CRISPR is Revolutionizing Cancer Research
Breakthrough gene-editing therapy transforms lives of patients with a hereditary disorder
CRISPR/Cas9 Leaders in Pharmaceutical Business Intelligence (LPBI) Group
Ovarian cancer – News, Research and Analysis – The Conversation – page 1
Home – Articles, Analysis, Opinion – The Conversation – page 499
CRISPR/Cas genome editing in triple negative breast cancer: Current situation and future directions - ScienceDirect
CRISPR Clinical Trials: A 2023 Update - Innovative Genomics Institute (IGI)
Genetically modified organism - Wikipedia
CRISPR - Noticias, Investigaciones y Análisis - The Conversation - página 4
Home – Articles, Analysis, Opinion – The Conversation – page 502
Genes, Free Full-Text
CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope, Cancer Cell International
New study finds that CRISPR/Cas9 leads to unexpected genomic changes
Breast cancer – News, Research and Analysis – The Conversation – page 3
Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy, Molecular Cancer
